Brian Goff insider trades: Agios Pharmaceuticals (AGIO) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Brian reports to the SEC
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 2, 2026 | AGIO | ↓ Sell | 19,068 | $34.71 | $662K | Direct | Apr 6, 2026 (4d) |
| Mar 2, 2026 | AGIO | ↓ Sell | 18,055 | $28.96 | $523K | Direct | Mar 3, 2026 (1d) |
| Dec 30, 2025 | AGIO | ↓ Sell | 18,703 | $27.09 | $507K | Direct | Jan 2, 2026 (3d) |
| Aug 8, 2025 | AGIO | ↓ Sell | 11,085 | $36.67 | $406K | Direct | Aug 12, 2025 (4d) |
| Jun 24, 2025 | AGIO | ↓ Sell | 18,700 | $33.54 | $627K | Direct | Jun 26, 2025 (2d) |
| Mar 3, 2025 | AGIO | ↓ Sell | 12,947 | $35.54 | $460K | Direct | Mar 4, 2025 (1d) |
| Aug 8, 2024 | AGIO | ↓ Sell | 11,091 | $42.75 | $474K | Direct | Aug 12, 2024 (4d) |
| Jun 5, 2024 | AGIO | ↓ Sell | 12,115 | $48.84 | $592K | Direct | Jun 7, 2024 (2d) |
| Mar 5, 2024 | AGIO | ↓ Sell | 4,156 | $32.57 | $135K | Direct | Mar 5, 2024 (0d) |
| Jan 24, 2024 | AGIO | ↓ Sell | 7,635 | $21.64 | $165K | Direct | Jan 24, 2024 (0d) |
| Jan 9, 2024 | AGIO | ↓ Sell | 12,066 | $22.99 | $277K | Direct | Jan 9, 2024 (0d) |
| Aug 8, 2023 | AGIO | ↓ Sell | 10,178 | $25.48 | $259K | Direct | Aug 10, 2023 (2d) |
| Jun 30, 2023 | AGIO | ↓ Sell | 11,449 | $28.36 | $325K | Direct | Jun 30, 2023 (0d) |
| Jun 8, 2018 | ALXN | ↓ Sell | 1,645 | $118.53 | $195K | Direct | Jun 12, 2018 (4d) |
| Feb 8, 2018 | ALXN | ↓ Sell | 1,651 | $116.31 | $192K | Direct | Feb 8, 2018 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other AGIO insiders
Open-market trades in the last 12 months
About Brian Goff's insider trades
Brian Goff is Chief Executive Officer at Agios Pharmaceuticals (AGIO). Since Feb 8, 2018, Brian has reported no open-market purchases and 15 sales worth $5.8M on SEC Form 4. In the last 12 months: 3 sales ($1.7M).
Their filings also include grants and awards (22 filings), option exercises (14 filings), shares withheld for taxes (11 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AGIO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.